Breaking News Instant updates and real-time market news.

FB

Facebook

$160.83

0.23 (0.14%)

, DISCA

Discovery

$31.53

-0.48 (-1.50%)

11:17
09/18/18
09/18
11:17
09/18/18
11:17

Fly Intel: Today's top analyst calls on Wall Street

Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN CUTS ESTIMATES, PRICE TARGET ON FACEBOOK: JPMorgan analyst Doug Anmuth lowered his 2019 and 2020 earnings estimates for Facebook (FB) by 5%-6% on the company's bigger investment increases over the next couple years, which he does not believe are fully captured in consensus estimates. Even with Facebook suggesting it could reach mid-30% operating margins in a few or several years, investments in 2019 could be larger than anticipated in consensus estimates, Anmuth said. The analyst also cut his price target for the shares to $195 from $205. However, he kept an Overweight rating on Facebook. PIVOTAL CUTS DISCOVERY TO SELL: Pivotal Research analyst Brian Wieser downgraded Discovery (DISCA) to Sell with an unchanged price target of $26. Despite "tepid" earnings and "underwhelming" longer-term trends, the stock is up 20% over the past month, Wieser noted. While Discovery's agreements with Hulu and Sling are positive, they do not meaningfully alter the company's fundamentals, the analyst added. His price target implies 19% downside from current share levels. MIZUHO BOOSTS AMD PRICE TARGET: Mizuho analyst Vijay Rakesh raised his price target for AMD (AMD) to $36 from $20 after meeting PC supply chain companies in Asia. AMD's expected server EPYC shipment spike in Q4 will be key, as Intel (INTC) continues to lack a CEO and a competitive technology response to AMD's 12nm Ryzen and 7nm Vega launch, Rakesh said. The analyst, who admits there could be "near-term bumps," kept a Buy rating on shares of AMD. CANACCORD SAYS KAPERNICK AD HAS 'OVERWHELMING' SUPPORT: Canaccord analyst Camilo Lyon conducted a proprietary survey to assess the impact of Nike's (NKE) "Just Do It" ad featuring former NFL quarterback Colin Kapernick. The findings suggest the impact was overall positive and he expects the company to confirm that when it reports Q1 results next week. He believes the ad has had the intended effect of positively skewing the company's brand perception and likely provided a bump in sales. Lyon reiterated his Buy rating and $95 price target on Nike shares. PIPER, WILLIAM BLAIR DEFEND NUTANIX: Nutanix (NTNX) shares dropped 11.5% Monday due to an article from The Information citing a potential competitive hyperconverged infrastructure offering from Google (GOOG, GOOGL), but Piper Jaffray analyst Andrew Nowinski views the selling pressure as "excessive" and reiterates an Overweight rating on Nutanix with a $66 price target. William Blair analyst Jason Ader called the fear of competition from Google "overblown" and reiterated an Outperform rating on Nutanix.

FB

Facebook

$160.83

0.23 (0.14%)

DISCA

Discovery

$31.53

-0.48 (-1.50%)

AMD

AMD

$31.70

-0.74 (-2.28%)

INTC

Intel

$46.20

0.78 (1.72%)

NKE

Nike

$84.83

1.58 (1.90%)

NTNX

Nutanix

$49.67

3.24 (6.98%)

GOOG

Alphabet

$1,167.71

11.33 (0.98%)

GOOGL

Alphabet Class A

$1,172.32

12.99 (1.12%)

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 25

    Sep

  • 21

    Oct

  • 22

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

FB Facebook
$160.83

0.23 (0.14%)

09/18/18
JPMS
09/18/18
NO CHANGE
Target $195
JPMS
Overweight
JPMorgan cuts estimates for Facebook, drops price target to $195
JPMorgan analyst Doug Anmuth lowered his 2019 and 2020 earnings estimates for Facebook (FB) by 5%-6% on the company's bigger investment increases over the next couple years, which he does not believe are fully captured in consensus estimates. The analyst says Facebook remains the most controversial company in his Internet coverage universe. The company is in transition as it pushes Stories more prominently on the core platform and rolls out stronger privacy tools for users. Even with Facebook suggesting it could reach mid-30%'s operating margins in a few or several years, investments in 2019 could be larger than anticipated in consensus estimates, Anmuth tells investors in a research note. The analyst also cut his price target for the shares to $195 from $205. However, he keeps an Overweight rating on the shares. Anmuth's top overall Internet picks are Amazon.com (AMZN), Twitter (TWTR) and Yelp (YELP.)
09/13/18
CLVD
09/13/18
NO CHANGE
CLVD
Buy
Cleveland Research lowers Facebook Q3 sales growth estimate
Cleveland Research analyst Chandler Converse said feedback on near-term Facebook ad spending has turned more cautious as a result of changes to limit targeting and tracking in response to increased scrutiny and regulation. The targeting and tracking changes are viewed as driving lower ROI for some advertisers, leading to reduced budget allocation, while Facebook also appears to be seeing increased competitive pressure from Google (GOOGL) and Amazon (AMZN), Converse tells investors. The analyst lowered his Q3 sales growth forecast to about 33% from a prior view of 35%, though he maintains a Buy rating on Facebook shares.
09/13/18
CLVD
09/13/18
NO CHANGE
CLVD
Facebook ad spend feedback turning more cautious, says Cleveland Research
09/14/18
PIPR
09/14/18
NO CHANGE
PIPR
Piper says Amazon, Facebook, Alphabet attractive despite regulatory pressure
Piper Jaffray analyst Michael Olson believes shares of Amazon.com (AMZN), Facebook (FB) and Alphabet (GOOG, GOOGL) remain attractive despite increased regulatory pressure in the near-term. While current regulatory challenges present "multiple issues over the next few months," the long-term outlook remains favorable for all three companies, Olson tells investors in a research note. The analyst believes Facebook may be becoming less exposed from a regulatory perspective going forward given that the company "has now done extensive work to bring its platform in line with recent privacy regulations and because it is now giving the deserved attention to privacy." Between the three companies, Alphabet may face the most regulatory headwind given its open infrastructure marketing platform exposure on privacy and targeting, susceptibility to copyright changes through YouTube, and its dominant position in search amenable to antitrust issues, the analyst contends. However, he believes Google, YouTube, Android, and Gmail together "create a once-in-a-generation asset with continued strong revenue growth potential, high margins, and secular tailwinds." For Amazon, Olson sees the biggest worries as antitrust and Post Office changes. However, he thinks antitrust law precedent will be upheld and points out the company continues to build its own last-mile delivery to lessen its dependency on the United States Postal Service.
DISCA Discovery
$31.53

-0.48 (-1.50%)

09/18/18
PIVT
09/18/18
DOWNGRADE
Target $26
PIVT
Sell
Discovery downgraded to Sell from Hold at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Discovery to Sell with an unchanged price target of $26. Despite "tepid" earnings and "underwhelming" longer-term trends, the stock is up 20% over the past month, Wieser tells investors in a research note. While Discovery's agreements with Hulu and Sling are positive, they do not meaningfully alter the company's fundamentals, the analyst adds. He notes his price target implies 19% downside from current share levels.
08/21/18
08/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPS DISCOVERY TO BUY: Jefferies analyst John Janedis upgraded Discovery (DISCA) to Buy from Hold and raised his price target for shares to $34 from $26, telling investors he sees "several" opportunities that could increase Discovery's free cash flow, including stronger U.S. distribution growth, upside to realized synergies and the potential for a re-introduction of a stock repurchase plan earlier than anticipated. Janedis said he believes the market is under-appreciating Discovery's relative stability and free cash flow generation. Discovery shares were higher by 3.4% in late morning trading. BOFA RAISES APPLE PRICE TARGET TO $250: BofA Merrill Lynch analyst Wamsi Mohan said his analysis of third-party data indicates that the relative contribution from games to App Store revenue is coming down and he views this diversifying away from gaming as bullish for Apple's (AAPL) Services business. The strong growth rate of non-gaming categories gives him increased confidence in the sustainability of strong App Store sales, leading the analyst to raise his Services revenue estimate and increase his price target on Apple shares to $250 from $230 with a Buy rating on the name. IMPERIAL STARTS MSG AT OUTPERFORM: Imperial Capital analyst David Miller initiated shares of Madison Square Garden (MSG) with an Outperform rating and $372 price target. Miller believes there is still "measurable upside" to full intrinsic value on a sum-of-the-parts basis. In addition, post the split-off from MSG Networks (MSGN) in October 2015, investors no longer have to worry about cord-cutting or any other secular concern affecting linear cable networks. Rather, MSG is focused completely on the "live" experience, with flagship assets that include the NY Knicks, the NY Rangers, and the real estate associated with iconic arenas such as the Forum in Los Angeles, Radio City Music Hall, the Chicago Theater, and the Garden itself. MORGAN STANLEY GOES RESTRICTED ON TESLA: Morgan Stanley is now restricted in terms of rating Tesla (TSLA), on which the firm previously had an Equal Weight rating. The Fly notes that on August 15, Goldman Sachs went to Not Rated on Tesla, with analyst David Tamberrino stating that the change was due to Goldman "acting as a financial advisor in connection with a matter that is fundamental to the reasonable analysis of the rating and price target for this stock." It may be that a similar situation is why Morgan Stanley is restricted in covering Tesla, though that has not been confirmed by the bank.
08/30/18
IMPC
08/30/18
NO CHANGE
Target $32
IMPC
Outperform
Discovery target raised to $32 on improving ratings at Imperial Capital
Imperial Capital analyst David Miller raised his price target for Discovery to $32 from $31 and maintains an Outperform rating on the shares. The company's anchor networks are seeing nice ratings improvements, Miller tells investors in a research note. He believes, however, that the company's improving ratings are being clouded by accounting and restructuring charges as well as currency moves. The analyst still expects Discovery to post $2.3B-plus of free cash flow generation in 2018.
09/18/18
09/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fortinet (FTNT) downgraded to Neutral from Buy at UBS with analyst Fatima Boolani saying the company's momentum appears priced into the shares at current levels. 2. United Continental (UAL) downgraded to Neutral from Outperform at Macquarie with analyst Susan Donofrio citing valuation. 3. Workiva (WK) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Stan Zlotsky saying the stock is the best performer of all stocks covered by the firm's Software team given its 50% move up over the last three months, which he attributes to heightened investor expectations, the near-term benefits from an extremely strong period within capital markets, and enthusiasm about the new CEO. 4. Discovery (DISCA) downgraded to Sell from Hold at Pivotal Research with analyst Brian Wieser saying despite "tepid" earnings and "underwhelming" longer-term trends, the stock is up 20% over the past month. 5. Apache (APA) downgraded to Hold from Buy at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMD AMD
$31.70

-0.74 (-2.28%)

09/18/18
MZHO
09/18/18
NO CHANGE
Target $36
MZHO
Buy
AMD price target raised to $36 from $20 at Mizuho
Mizuho analyst Vijay Rakesh raised his price target for AMD (AMD) to $36 from $20 after meeting PC supply chain companies in Asia. The chipmaker closed yesterday down 29c to $32.43. AMD's expected server EPYC shipment spike in Q4 will be key, as Intel (INTC) continues to lack a CEO and a competitive technology response to AMD's 12nm Ryzen and 7nm Vega launch, Rakesh tells investors in a research note. The analyst, who admits there could be "near-term bumps," keeps a Buy rating on shares of AMD after raising his server estimates.
09/14/18
ARGS
09/14/18
NO CHANGE
Target $40
ARGS
Buy
AMD price target raised to $40 from $23 at Argus
Argus analyst Jim Kelleher raised his price target on AMD (AMD) to $40 and kept his Buy rating, saying the company's Epyc server chips are increasingly becoming a threat to Intel (INTC) dominance in data center CPUs, while its Ryzen is used in "more and more desktop and notebook PCs". The analyst states that even though investors' enthusiasm for the stock "risks outstripping fundamentals", he does not see AMD shares becoming overvalued as the company is growing momentum and strengthening the capability of its computing chips while Intel stumbles.
09/13/18
09/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MORGAN STANLEY CUTS FINISAR, CIENA TO EW: Morgan Stanley analyst Meta Marshall downgraded both Finisar (FNSR) and Ciena (CIEN) to Equal Weight from Overweight, as she adjusted her Optical Scorecard following the earnings reports from companies in the sector. The two stocks have closed the short-term valuation gaps that she previously believed existed with their respective moves up, Marshall said. The analyst added that she is being cautious ahead of Ciena's FY19 guidance, though she raised her price target on the stock to $32 from $30. Marshall, who kept a $20 price target on Finisar shares, said she thinks its catalysts don't come until calendar 2019. The analyst also noted that she is now Equal Weight on the space as a whole, as she also has Equal Weight ratings on Lumentum (LITE), II-VI (IIVI) and Acacia Communications (ACIA). BOFA CUTS WAYFAIR TO NEUTRAL: BofA Merrill Lynch analyst Askshay Bhatia downgraded Wayfair (W) to Neutral from Buy and raised its price target to $160 from $130. Bhatia believes growth is likely to decelerate ahead and sees increasing investments into 2019. Combining that with shares that are up 86% year-to-date leaves little room for further upside, the analyst added. SNAP UPPED TO HOLD FOLLOWING SELLOFF: Pivotal Research analyst Brian Wieser upgraded Snap (SNAP) to Hold from Sell with an unchanged price target of $9. Risks are still present, especially in the near-term, but current trading levels balance those risks with the company' long-term potential, Wieser said. Risks include "aggressive competition from much larger companies," a core user base that is "not growing by much and is only relatively elusive," and a "sub-optimal corporate structure," according to the analyst. BERNSTEIN STARTS NIO WITH UNDERPERFORM: Bernstein analyst Robin Zhu started coverage of NIO Inc. (NIO) with an Underperform rating and $4.20 price target. While the analyst is intrigued by many things, from its impressive branding to its massive volume ambitions, he is unconvinced NIO's shares represent a sound investment. Further, Zhu is skeptical the Chinese electric carmaker can achieve its volume targets. FBN STARTS AMD WITH OUTPERFORM: FBN Securities analyst Shelby Sayrafi initiated coverage of AMD (AMD) with an Outperform rating and $40 price target. AMD currently has a "strong" new product cycle driven by its Zen architecture, fifth generation graphics chips and EPYC processors for the enterprise server market that are "all ramping well currently," Sayrafi said. The analyst believes the EPYC server chip could help AMD penetrate the $16B server chip market.
09/13/18
FBNS
09/13/18
INITIATION
Target $40
FBNS
Outperform
FBN Securities starts AMD with Outperform rating, $40 price target
FBN Securities analyst Shelby Sayrafi initiated coverage of AMD (AMD) with an Outperform rating and $40 price target. The chipmaker closed yesterday up 7%, or $2.11, to $32.21. AMD currently has a "strong" new product cycle driven by its Zen architecture, fifth generation graphics chips and EPYC processors for the enterprise server market that are "all ramping well currently," Sayrafi tells investors in a research note. The analyst believes the EPYC server chip could help AMD penetrate the $16B server chip market. Further, AMD sells semi-custom chips to Microsoft (MSFT) and Sony (SNE), two of the three leading game hardware companies, Sayrafi adds.
INTC Intel
$46.20

0.78 (1.72%)

09/13/18
DBAB
09/13/18
NO CHANGE
Target $23
DBAB
Hold
Deutsche Bank boosts AMD target, but says 'goodness' fully priced in
Deutsche Bank analyst Ross Seymore raised his price target for AMD (AMD) to $23 from $14 after hosting the company's CFO Devinder Kumar at his firm's 2018 Tech Conference. The chipmaker closed yesterday up 7%, or $2.11, to $32.21. The analyst found Kumar's comments to be positive, noting the company reiterated its product-specific growth drivers and share gain plans within the server, graphics, and PC markets. Seymore continues to be impressed by AMD's execution with the company "capitalizing not only on its strong new product traction but also on competitor missteps." However, even with his raised 2020 estimates, the analyst believes "the goodness at AMD is already fully reflected in its share price." The stock's current valuation is elevated at 34 times consensus 2020 earnings estimates, Seymore tells investors in a research note. Further, he believes upside in earnings to the most bullish estimates likely ignores the potential for competitive responses from Intel (INTC) and Nvidia (NVDA). Seymore keeps a Hold rating on AMD.
09/13/18
09/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying risks are still present, especially in the near-term, but current trading levels balance those risks with the company' long-term potential. 2. DaVita (DVA) upgraded to Neutral from Underweight at JPMorgan with analyst Gary Taylor saying he now believes is it much more likely that California Governor Brown will veto the recently passed SB1156, which he notes would curtail the financial arbitrage that dialysis providers enjoy from charitable premium assistance. 3. Intel (INTC) upgraded to Market Perform from Underperform at Northland with analyst Auguste Richard saying the stock has corrected 23% from its 52-week high and is down 20% since mid-June. 4. Magna (MGA) upgraded to Outperformer from Neutral at CIBC. 5. Flowserve (FLS) upgraded to Buy from Neutral at Northcoast. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NKE Nike
$84.83

1.58 (1.90%)

09/17/18
PIPR
09/17/18
NO CHANGE
Target $93
PIPR
Overweight
Piper remains positive on Nike shares ahead of Q1 results
Piper Jaffray analyst Erinn Murphy remains positive on shares of Nike ahead of the company's fiscal Q1 results on September 25. The analyst sees upside to her Q1 sales and gross margin estimates, driven by "solid" domestic demand, strength in China and "on-going traction" in Europe. While currencies have been more volatile, upside on a constant currency basis and a strengthening fundamental backdrop should still support earnings and the stock moving higher over the near- to medium-term, Murphy tells investors in a pre-earnings research note. Further, the analyst's checks indicate Nike outperformed peer promotional levels and inventory management during back-to-school. She keeps an Overweight rating on the shares with a $93 price target.
09/13/18
SBSH
09/13/18
NO CHANGE
SBSH
Buy
Nike possible slowdown in China something to watch, says Citi
Greater China has been an important contributor to Nike's top and bottom line, driving a quarter of revenue growth and a third of Nike Brand EBIT growth over the past five years, Citi analyst Kate McShane tells investors in a research note titled "Nike's Dance w/ China Has Been Great, What if the Music Stops?" The analyst isn't calling for a slowdown in China, but she feels risks around a possible softening of China retail consumption and potential for tariff threats are something to watch. The analyst, however, remains a buyer of Nike shares.
09/18/18
NEED
09/18/18
NO CHANGE
NEED
Hold
Nike positioned for 'solid' Q1, says Needham
Needham analyst Rick Patel is keeping his Hold rating on Nike ahead of its Q1 earnings next week based on its "premium valuation", even though he expects the company to post "solid results". The analyst cites his proprietary domestic checks suggesting "sequential improvement in promos and average selling prices". Patel also points to a favorable Q2 read-through from other athletic apparel names in the quarter, along with the "lean" inventory of Nike's wholesale customers. The analyst further anticipates outperformance in Nike's international segment based on its "strong brand and product momentum".
09/18/18
ADAM
09/18/18
NO CHANGE
Target $95
ADAM
Buy
Survey shows overwhelming support for Nike's Kapernick ad, says Canaccord
Canaccord analyst Camilo Lyon conducted a proprietary survey to assess the impact of Nike's "Just Do It" ad featuring former NFL quarterback Colin Kapernick. The findings suggest the impact was overall positive and he expects the company to confirm that when it reports Q1 results next week. He believes the ad has had the intended effect of positively skewing the company's brand perception and likely provided a bump in sales. Lyon reiterated his Buy rating and $95 price target on Nike shares.
NTNX Nutanix
$49.67

3.24 (6.98%)

09/18/18
PIPR
09/18/18
NO CHANGE
Target $66
PIPR
Overweight
Piper calls Nutanix selloff on Google competition concerns 'excessive'
Nutanix (NTNX) shares dropped 11.5% yesterday due to an article from The Information citing a potential competitive hyperconverged infrastructure offering from Google (GOOG, GOOGL), Piper Jaffray analyst Andrew Nowinski tells investors in a research note. According to the article, Google is building custom-designed hyperconverged infrastructure solutions for a handful of large customers that will run inside these customers' private datacenters. While the potential offering could be viewed as competitive to Nutanix, most enterprises will choose to leverage a multi-cloud infrastructure and would not want to be locked into single cloud provider, Nowinski contends. As such, the analyst views yesterday's selling pressure as "excessive" and reiterates an Overweight rating on Nutanix with a $66 price target. The stock closed yesterday down $6.07 to $46.47.
08/31/18
KEYB
08/31/18
NO CHANGE
Target $68
KEYB
Overweight
KeyBanc remains buyer of Nutanix after 'strong' Q4 results
KeyBanc analyst Alex Kurtz says Nutanix last night delivered "solid" software and support billings up 66% year-over-year, driven by ongoing large deal strength and growth in Global 2000 repeat purchases. He attributes the post-earnings pullback to the company's "aggressive" spending model and the lower Q1 revenue guidance due to a faster transition from hardware revenue. The analyst, however, views the Q4 print as "strong" and remains a buyer of the shares with an Overweight rating and $68 price target.
08/31/18
JMPS
08/31/18
NO CHANGE
Target $60
JMPS
Outperform
Nutanix increased spending prudent, says JMP Securities
JMP Securities analyst Erik Suppiger noted that Nutanix shares traded down 6% in the afterhours following its Q4 report, which he attributes to guidance that reflects continued top-line momentum but higher expenses as the company invests in both sales and products. He thinks the increased spending is prudent given the company's large market opportunity and sees the strength in billings, driven by strong performance in large accounts, continuing to fuel growth. Suppiger maintain his Outperform rating and $60 price target on Nutanix shares, which he continues to view as undervalued.
09/18/18
WBLR
09/18/18
NO CHANGE
WBLR
Outperform
Fears of Google competition for Nutanix look overblown, says William Blair
Shares of Nutanix (NTNX) fell yesterday after The Information reported that Google (GOOG, GOOGL) is working on a potential hyperconverged infrastructure product that could conceptually compete with Nutanix, William Blair analyst Jason Ader tells investors in a research note titled "Fears of Google Entering HCI Space Look Overblown to Us". This is likely Google's response to what Microsoft (MSFT) has built with Azure Stack, which is Microsoft's HCI product that connects directly into its Azure public cloud service, Ader contends. He believes that if Google turn this into an actual packaged HCI product sold to a broad range of customers, it could create longer-term risk for Nutanix. However, thinks investors should consider that this appears to be another validation of the staying power of the on-premises market, which he says bodes well for Nutanix. Further, he points out that if Google were to decide to enter the HCI market more broadly, it would have a long way to go to establish itself in the enterprise against entrenched players like Nutanix and VMware (VMW). Google has not had great success selling into the enterprise historically and has little experience selling enterprise infrastructure appliances, Ader writes. The analyst reiterates an Outperform rating on Nutanix.
GOOG Alphabet
$1,167.71

11.33 (0.98%)

09/14/18
LSCM
09/14/18
NO CHANGE
Target $90
LSCM
Buy
Apple Watch more likely a positive for BioTelemetry, says Lake Street
After spending time with Joe Capper and Heather Getz, CEO and CFO of BioTelemetry (BEAT), Lake Street analyst Brooks O'Neil senses that Apple's (AAPL) Watch Series 4, which includes a built-in electrocardiogram, is more likely a positive for BioTelemetry "than a buzzer sounding a flat-line for the company's future." BioTelemetry remains the leading cardiac monitoring company and this is likely to continue for the foreseeable future, O'Neil tells investors in a research note. He points out the company has a partnership with Apple in cardiac monitoring and with Sanofi (SNY) and Alphabet (GOOG) in diabetes. The analyst's guesses that its partnership is one element giving BioTelemetry management comfort in evaluating the role Apple might play in the company's future. O'Neil reaffirms a Buy rating on the shares with a $90 price target.
GOOGL Alphabet Class A
$1,172.32

12.99 (1.12%)

09/12/18
SBSH
09/12/18
NO CHANGE
SBSH
Amazon remains Citi's top pick in U.S. Internet
Citi analyst Mark May keeps Amazon.com (AMZN) as his top pick in U.S. Internet based on recent data points pertaining to company fundamentals, the near-term setup, recent stock performance, investor sentiment and changes since his last update. Alphabet (GOOG, GOOGL), Yelp (YELP), Expedia (EXPE), GrubHub (GRUB) and GoDaddy (GDDY) moved up in his rankings while Facebook (FB), eBay (EBAY), Twitter (TWTR), TripAdvisor (TRIP) and Booking Holdings (BKNG) moved down.

TODAY'S FREE FLY STORIES

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

SBLK

Star Bulk Carriers

$8.21

0.13 (1.61%)

17:03
02/15/19
02/15
17:03
02/15/19
17:03
Hot Stocks
Star Bulk Carriers acquires 95,605 of its common shares »

Star Bulk Carriers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$20.56

0.26 (1.28%)

17:02
02/15/19
02/15
17:02
02/15/19
17:02
Earnings
Hollysys reports Q2 adjusted EPS 73c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AKS

AK Steel

$2.98

-0.015 (-0.50%)

16:58
02/15/19
02/15
16:58
02/15/19
16:58
Syndicate
Breaking Syndicate news story on AK Steel »

AK Steel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
02/15/19
02/15
16:55
02/15/19
16:55
General news
Treasury Market Summary: i »

Treasury Market Summary:…

LPTX

Leap Therapeutics

$1.65

(0.00%)

16:53
02/15/19
02/15
16:53
02/15/19
16:53
Hot Stocks
Valence Helix Investments discloses 10.99% stake in Leap Therapeutics »

Valence Helix disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$23.25

-0.24 (-1.02%)

16:52
02/15/19
02/15
16:52
02/15/19
16:52
Hot Stocks
Mid Penn Bancorp seeks approval to relocate Allentown Boulevard branch »

Mid Penn Bank, subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$423.79

8.54 (2.06%)

, AMGN

Amgen

$188.31

1.6 (0.86%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
Regeneron says EPO revokes Immunex's European patent No. 2,990,420 »

Regeneron…

REGN

Regeneron

$423.79

8.54 (2.06%)

AMGN

Amgen

$188.31

1.6 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 28

    Apr

  • 13

    May

UPS

UPS

$110.89

-0.91 (-0.81%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
UPS CFO sells 9.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DAL

Delta Air Lines

$51.09

0.58 (1.15%)

16:43
02/15/19
02/15
16:43
02/15/19
16:43
Syndicate
Breaking Syndicate news story on Delta Air Lines »

Delta Air Lines files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$110.89

-0.91 (-0.81%)

16:42
02/15/19
02/15
16:42
02/15/19
16:42
Hot Stocks
UPS raises quarterly dividend to 96c per share from 91c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.